FDA Approves New Antibody Drug to Fight Omicron Variant
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the Omicron variant. The emergency use authorization for bebtelovimab is for the treatment of mild to moderate COVID-19 in adults and pediatric patientsContinue Reading










